Heron Therapeutics, Inc.

Historical 13F Holders

Symbol
HRTX
CUSIP
427746102
All holders as of
Q1 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q1 173 156 M $125 M
2025 Q4 175 156 M $206 M
2025 Q3 177 154 M $194 M
2025 Q2 177 135 M $279 M
2025 Q1 171 125 M $275 M
2024 Q4 168 115 M $176 M
2024 Q3 178 122 M $243 M
2024 Q2 197 130 M $457 M
2024 Q1 170 120 M $332 M
2023 Q4 161 114 M $194 M
2023 Q3 145 118 M $122 M
2023 Q2 154 98.9 M $115 M
2023 Q1 165 108 M $163 M
2022 Q4 184 118 M $296 M
2022 Q3 194 122 M $516 M
2022 Q2 184 115 M $322 M
2022 Q1 204 109 M $621 M
2021 Q4 219 118 M $1.08 B
2021 Q3 207 108 M $1.16 B
2021 Q2 202 104 M $1.61 B
2021 Q1 212 91.1 M $1.48 B
2020 Q4 202 90.9 M $1.92 B
2020 Q3 192 90.9 M $1.35 B
2020 Q2 210 88.6 M $1.33 B
2020 Q1 218 92.8 M $1.10 B
2019 Q4 213 100 M $2.35 B
2019 Q3 198 91.4 M $1.69 B
2019 Q2 197 94.1 M $1.75 B
2019 Q1 218 93.0 M $2.27 B
2018 Q4 195 92.1 M $2.39 B
2018 Q3 218 88.7 M $2.81 B
2018 Q2 224 86.5 M $3.36 B
2018 Q1 176 82.0 M $2.26 B
2017 Q4 145 69.0 M $1.25 B
2017 Q3 119 63.4 M $1.02 B
2017 Q2 120 69.6 M $964 M
2017 Q1 111 71.8 M $1.08 B
2016 Q4 111 52.8 M $692 M
2016 Q3 106 51.3 M $883 M
2016 Q2 104 47.0 M $848 M
2016 Q1 115 45.0 M $855 M
2015 Q4 124 45.4 M $1.21 B
2015 Q3 122 46.3 M $1.13 B
2015 Q2 99 36.2 M $1.13 B
2015 Q1 73 26.4 M $385 M
2014 Q4 65 24.6 M $247 M
2014 Q3 59 24.4 M $203 M
2014 Q2 71 29.4 M $363 M
2014 Q1 40 20.8 M $289 M